Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-24255

Single-particle
3.8 Å
EMD-24255
3D View Gallery
Deposition: 17/06/2021
Map released: 04/08/2021
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-24255
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 7n9b summary report (pdf.gz) Map and 7n9b FULL report (pdf.gz)
EMICSS annotations (xml)

SARS-CoV-2 S with NB21 nanobody

EMD-24255

Single-particle
3.8 Å
EMD-24255
3D View Gallery
Deposition: 17/06/2021
Map released: 04/08/2021
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Lama glama
Sample: SARS Cov 2 Spike S with Nanobody Nb21
Fitted models: 7n9b

Deposition Authors: Sun D, Zhang C
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes
Sun D, Sang Z, Kim YJ, Xiang Y, Cohen T, Belford AK, Huet A, Conway JF, Sun J, Taylor DJ, Schneidman-Duhovny D, Zhang C, Huang W, Shi Y
(2021) Nat Commun , 12 , 4676
DOI: doi:10.1038/s41467-021-24963-3
ISSN: 2041-1723